Growth rate-corrected (GR) dose-response metrics across a panel of 71 breast cancer cell lines treated with a library of small molecule and antibody perturbagens. Dataset 2 of 4: Calculated dose-response metrics. - Dataset (ID:20269)

Filter results: >>>>
Cell Clinical Subtype Transcriptional Subtype Small Molecule Antibody Perturbagen Target Perturbagen Class Biological Replicate ID Conc Unit GR50 GEC50 GRmax GRinf GR Hill Coefficient GR_AOC GR r2 Nominal Division Rate
HCC1806
TNBC
Basal A
Ixabepilone
TUBB
TUBB
7451.095
uM
0.00335
0.00636
-0.8230 -0.3798 0.8819 0.8966
0.8817
2.2028
HCC1806
TNBC
Basal A
Ixabepilone
TUBB
TUBB
7450.095
uM
0.00797
0.01154
-0.8836 -0.4702 1.7890 0.8890
0.9427
1.7844
HCC1806
TNBC
Basal A
JNK-IN-5A
JNK
JNK
12239.144
uM
119.91440
163.06790
0.3489 -1.0000 3.5740 0.0798
0.7292
2.1598
HCC1806
TNBC
Basal A
L-779450
BRAF
MAPK
12239.161
uM
13.15840
21.02110
-0.7694 -1.0000 2.3451 0.1301
0.9958
1.8129
HCC1806
TNBC
Basal A
Lapatinib
EGFR/HER2
ErbB
7450.098
uM
inf
1.66810
0.9020 0.9019 3.3261 0.0024
0.7525
2.2139
HCC1806
TNBC
Basal A
LBH589
HDAC
HDAC
12239.154
uM
0.21396
0.33108
-0.7674 -0.7837 2.1598 0.6557
0.9954
2.2015
HCC1806
TNBC
Basal A
Lestaurtinib
FLT3/JAK2/TrkA
RTK
12239.154
uM
0.17076
0.33908
-0.7290 -0.6804 1.2522 0.5946
0.9966
2.2015
HCC1806
TNBC
Basal A
Mebendazole
12702.174
uM
0.29217
0.33503
-0.2552 -0.1582 2.0078 0.4906
0.9887
1.8506
HCC1806
TNBC
Basal A
Methotrexate
DHFR
Metabolism
7450.084
uM
inf
inf
0.9424 0.9424 0.0000 0.0000
0.5666
2.3432
HCC1806
TNBC
Basal A
Methotrexate
DHFR
Metabolism
7451.085
uM
0.00695
0.00649
0.1463 0.1465 5.0000 0.7130
0.9890
2.1458
HCC1806
TNBC
Basal A
Methylglyoxal
13543.184
uM
63.26310
271.02190
-0.9881 -1.0000 0.7551 0.8885
0.8997
1.5433
HCC1806
TNBC
Basal A
MG-132
Proteasome
Proteasome
14155.189
uM
inf
inf
-0.8537 -0.8537 0.0000 0.5966
0.5536
1.7812
HCC1806
TNBC
Basal A
MG-132
Proteasome
Proteasome
14155.189
uM
inf
inf
-0.8537 -0.8537 0.0000 0.5966
0.5536
1.7812
HCC1806
TNBC
Basal A
MG-132
Proteasome
Proteasome
14128.189
uM
inf
inf
-0.6315 -0.6315 0.0000 0.4616
0.5621
2.7793
HCC1806
TNBC
Basal A
MG-132
Proteasome
Proteasome
14128.189
uM
inf
inf
-0.6315 -0.6315 0.0000 0.4616
0.5621
2.7793
HCC1806
TNBC
Basal A
MG-132
Proteasome
Proteasome
14634.189
uM
0.56342
0.86102
-0.7560 -0.7391 2.1399 0.6123
0.9966
2.1561
HCC1806
TNBC
Basal A
MG-132
Proteasome
Proteasome
14634.189
uM
0.56342
0.86102
-0.7560 -0.7391 2.1399 0.6123
0.9966
2.1561
HCC1806
TNBC
Basal A
MG-132
Proteasome
Proteasome
12239.145
uM
0.30347
0.41921
-0.7519 -0.7356 2.8001 0.6909
0.9996
2.1348
HCC1806
TNBC
Basal A
MG-132
Proteasome
Proteasome
12239.145
uM
0.30347
0.41921
-0.7519 -0.7356 2.8001 0.6909
0.9996
2.1348
HCC1806
TNBC
Basal A
Pevonedistat
NAE1
NAE1
12239.135
uM
0.02626
0.04694
-0.4881 -0.3585 0.9307 0.7524
0.9887
2.0860
HCC1806
TNBC
Basal A
Nelfinavir
12702.174
uM
8.77290
11.30080
-0.8571 -0.8812 4.0129 0.1752
0.9941
1.8506
HCC1806
TNBC
Basal A
Nilotinib
ABL
nRTK
12239.145
uM
inf
inf
0.9597 0.9597 0.0000 0.0201
-0.0222
2.1348
HCC1806
TNBC
Basal A
NSC 663284
CDC25
CDC
12239.152
uM
2.4250
3.86620
-0.7736 -0.7755 2.0078 0.5464
0.9946
2.2104
HCC1806
TNBC
Basal A
NU6102
CDK1/2
CDK
12239.147
uM
17.5460
20.68470
-0.6115 -0.6167 4.8829 0.1214
0.9982
2.0027
HCC1806
TNBC
Basal A
Nutlin 3a
MDM2
MDM2
7450.066
uM
167.60080
439.27520
0.7696 -0.8645 1.0419 0.0355
0.8036
2.3863